Ajna BioSciences and British American Tobacco, yielded positive results from a phase-1 dose trial of AJA001, its cannabis-based drug candidate to treat symptoms of autism spectrum disorder ・Results ...
Technology stocks were helping prop up the broader market on Wednesday while the Dow was struggling for direction. The S&P 500's communication services sector was the best performer among the ...